Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Cellebrite DI Ltd. (NASDAQ: CLBT)
CLBT Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
5.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
46%
CLBT Stock Analysis
CLBT
PE Ratio:
50.6
CLBT
PEG Ratio:
2.9
CLBT
Forward EPS Growth (12 month):
17.70%
CLBT
PS Ratio:
7.1
CLBT
PSG Ratio:
0.4
CLBT
Forward Revenue Growth (12 month):
17.60%
CLBT Articles
No data was found